T2 Biosystems is a developer of a next-generation medical diagnostic platform that enables rapid and accurate diagnostic tests.
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
Pulmatrix develops inhaled therapies for the treatment, prevention, and transmission of infectious and progressive respiratory diseases.
Aldeyra Therapeutics develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases.
Translate Bio develops medicines to treat diseases caused by protein or gene dysfunction.
Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
MC10 develops virtually invisible, conformal electronics that reshape rigid conventional electronics into thin flexible devices.
Fractyl Laboratories is a company developing solutions for the treatment of chronic diseases.
Kaleido Biosciences is a biotechnology company that discovers and develops therapeutic treatments for the patients with diseases.
NDB develops enhanced condensation and anti-wetting surface coatings adjoining macromolecular chemistry.
Taris is building a unique therapeutically-focused urology company developing powerful and targeted new treatments for millions of patients suffering from difficult-to-treat bladder diseases.